vimarsana.com

லெவிஸ் க்யாட்ஸ் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

For the last seven years, researchers at the Lewis Katz School of Medicine at Temple University have been developing and refining CRISPR-based gene-editing technology for the treatment of human immunodeficiency virus type 1 (HIV) infection.

PHL Inno - Lab notes: Temple spinout advances gene-editing HIV treatment; 3 firms make board appointments

PHL Inno - Lab notes: Temple spinout advances gene-editing HIV treatment; 3 firms make board appointments
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

Pharma, Research, And Medical Leaders Say Kidney Patients Are Key To Care Innovation

Pharma, Research, And Medical Leaders Say Kidney Patients Are Key To Care Innovation
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.